, Tracking Stock Market Picks
Enter Symbol:
Amarin Corporation Plc (AMRN) [hlAlert]

down 87.61 %

Amarin Corporation Plc (AMRN) downgraded to Hold with price target $3 by Canaccord Genuity

Posted on: Thursday,  Oct 17, 2013  9:25 AM ET by Canaccord Genuity

Canaccord Genuity rated Hold Amarin Corporation Plc (NASDAQ: AMRN) on 10/17/2013. Previously Canaccord Genuity rated Buy Amarin Corporation Plc (NASDAQ: AMRN) on
04/18/2011., when the stock price was $15.74. Since then, Amarin Corporation Plc has lost 87.61% as of 10/17/2013's recent price of $1.95.
If you would have followed the previous Canaccord Genuity's recommendation on AMRN, you would have lost 87.61% of your investment in 913 days.

Amarin Corporation plc (Amarin) is a late-stage biopharmaceutical company with a focus on cardiovascular disease. Amarin has a range of clinical and preclinical stage compounds to treat central nervous system (CNS) disorders, including Huntington?s disease, myasthenia gravis and Parkinson?s disease. Its cardiovascular programs and non-core CNS programs include AMR101, EN101, Sublingual Apomorphine and AMR 103. The Company's subsidiaries include Amarin Neuroscience Limited, Amarin Pharmaceuticals Ireland Limited, Amarin Pharma Inc, Amarin Finance Limited and Ester Neurosciences Limited.

Canaccord Genuity’s global team of over 100 research professionals are inquisitive, experienced and committed to generating actionable investment ideas. We analyze over 725 companies in a broad range of market sectors, identifying value and defining risk for our clients.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/17/2013 9:25 AM Hold
1.95 3.00
as of 12/13/2013
1 Week   
1 Month   
3 Months down  -70.45 %
1 YTD down  -75.89 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/18/2011 9:25 AM Buy
15.74 18.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy